The 2024 Annual Scientific Meeting (ASM) will be held at the Cairns Convention Centre in Queensland, Australia, from 24-26 July.

2024 Annual Scientific Meeting

This is the 45th year of the conference, which will be held in association with the Japanese Clinical Oncology Group (JCOG) and the Korean Breast Cancer Study Group (KBCSG), and is the foremost meeting for breast cancer clinical trials research in Australasia.

Hosting a number of internationally renowned guest speakers including key BCT researchers, delegates include leading Australian and New Zealand medical practitioners and clinicians, and clinical trials management personnel.

The full and extensive program will include two days of scientific sessions covering timely reviews of breast cancer clinical trials, discussion of new protocols, future clinical trials research, and other research developments.

The ASM will also include abstracts, debates, and is followed by a two-day trainee and early-career weekend. The theme for the ASM will be International Collaboration in Breast Cancer Trials, and we look forward to colleagues joining the meeting.

Sessions will be dedicated to key issues on the prevention and treatment of early and advanced breast cancer and to the supportive care of those affected. Current and future trials, and research directions, will be discussed and new approaches analysed.

The ASM is a great opportunity to network with research colleagues from around Australasia and the world, and to also hear new ideas for clinical trials in the future.

International Guest Speakers for 2024 include Michael Gnant, Andrew Tutt, Elinor Sawyer, Erica Mayer, Carlos Barrios, Peter Barry, In Hae Park, and Akihiko Shimomura.

For more information about the 2024 Breast Cancer Trials Annual Scientific Meeting please visit our ASM website.


If you would like more information about the Annual Scientific Meeting, including registration and sponsorship, please email the ASM Secretariat.